Physician profile
Ashley E Goldsmith
NPI 1669776308
$367.75
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $54.08 · 2023: $85.57 · 2024: $36.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $120.13 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $86.02 | 2021-2024 | Caldolor |
| Kci USA, INC. | $57.68 | 2021-2023 | Prevena Restor Bellaform, V.A.C. Veraflo, V.A.C. Dermatac |
| Janssen Pharmaceuticals, INC | $41.35 | 2021-2023 | Xarelto |
| Shionogi INC | $40.68 | 2021-2022 | |
| Melinta Therapeutics, LLC | $21.89 | 2024 | Rezzayo, Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.